Standardization is an integral step in improving and modernizing the clinical trial design and build process. But how are organizations achieving standardization? What role does technology have to play? And what impact is it having?
We explore this and discuss the role of metadata standardization in end-to-end trial design and build.
Attendees will hear the story of global biopharmaceutical companies we're working with, and how they've leveraged technology to drive standardization. We'll cover effective strategies, how to avoid the pitfalls, and also a best practice blueprint for others to follow.